Your browser doesn't support javascript.
Nanobodies: an unexplored opportunity to combat COVID-19.
Ezzikouri, Sayeh; Nourlil, Jalal; Tsukiyama-Kohara, Kyoko; Kohara, Michinori; El Ossmani, Hicham; Windisch, Marc P; Benjelloun, Soumaya.
  • Ezzikouri S; Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
  • Nourlil J; Transboundary Animal Diseases Centre, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
  • Tsukiyama-Kohara K; Medical Virology and BSL3 Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
  • Kohara M; Transboundary Animal Diseases Centre, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
  • El Ossmani H; Department of Microbiology and Cell Biology, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Windisch MP; Institut de Criminalistique de la Gendarmerie Royale, Rabat, Morocco.
  • Benjelloun S; Applied Molecular Virology Laboratory, Discovery Biology Department, Institut Pasteur Korea, Gyeonggi-do, South Korea.
J Biomol Struct Dyn ; 40(7): 3129-3131, 2022 04.
Article in English | MEDLINE | ID: covidwho-917572
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). This virus is capable of human-to-human transmission, and is spreading rapidly round the globe, with markedly high fatality rates. Unfortunately, there are neither vaccines nor specific therapies available to combat it, and the developments of such approaches depend on pursuing multiple avenues in biomedical science. Accordingly, in this paper we highlight one such avenue-nanobodies-for potential utility in therapeutic and diagnostic interventions to combat COVID-19.Communicated by Ramaswamy H. Sarma.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Single-Domain Antibodies / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Biomol Struct Dyn Year: 2022 Document Type: Article Affiliation country: 07391102.2020.1845801

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Single-Domain Antibodies / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Biomol Struct Dyn Year: 2022 Document Type: Article Affiliation country: 07391102.2020.1845801